| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.023 | 0.9 |